Long-lived min mice develop advanced intestinal cancers through a genetically conservative pathway

Cancer Research

Volumn 69, Issue 14, 2009, Pages 5768-5775

  Halberg, Richard B ^a,g   Waggoner, Jesse ^a   Rasmussen, Kristen ^a   White, Alanna ^a   Clipson, Linda ^a   Prunuske, Amy J ^a   Bacher, Jeffery W ^c   Sullivan, Ruth ^a,b   Washington, Mary Kay ^d   Pitot, Henry C ^a   Petrini, John H J ^a,f   Albertson, Donna G ^e   Dove, William F ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c PROMEGA CORPORATION   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NIBRIN;

ADVANCED CANCER; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FAMILIAL CANCER; FEMALE; GENETIC CONSERVATION; GENETIC STABILITY; HISTOPATHOLOGY; INTESTINE ADENOCARCINOMA; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MALE; MESENTERY; MICROSATELLITE INSTABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ADENOCARCINOMA; ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; ALKYLATING AGENTS; ANIMALS; CELL CYCLE PROTEINS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ETHYLNITROSOUREA; FECES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL NEOPLASMS; INTESTINES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MUTATION; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 67651007283     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0446     Document Type: Article

References (48)

1. Cancer facts & figures 2008. Atlanta (GA): American Cancer Society; 2008.
2. Threadgill DW. Metastatic potential as a heritable trait. Nat Genet 2005;37:1026-7.
3. McCart AE, Vickaryous NK, Silver A. Apc mice: models, modifiers and mutants. Pathol Res Pract 2008; 204:479-90.
4. Kwong LN, Dove WF. APC and its modifiers in colon cancer. In: Nathke I, McCartney B, editors. APC proteins. Austin: Landes Bioscience; 2008.
5. Hinoi T, Akyol A, Theisen BK, et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res 2007;67:9721-30.
6. Kucherlapati M, Nguyen A, Kuraguchi M, et al. Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies. Oncogene 2007;26:6297-306.
7. -/- mice. Am J Pathol 2005;166:1239-46.
8. Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell 1998;94:703-14.
9. Engle SJ, Hoying JB, Boivin GP, et al. Transforming growth factor h1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res 1999;59:3379-86.
10. Fodde R, Edelmann W, Yang K, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci U S A 1994;91:8969-73.
11. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-9.
12. Williams BR, Mirzoeva OK, Morgan WF, et al. A murine model of Nijmegen breakage syndrome. Curr Biol 2002;12:648-53.
13. Riley LK, Franklin CL, Hook RR, Jr., Besch-Williford C. Identification of murine Helicobacter by PCR and restriction enzyme analyses. J Clin Microbiol 1996;34:942-6.
14. Halberg RB, Katzung DS, Hoff PD, et al. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci U S A 2000;97:3461-6.
15. Haigis KM, Caya JG, Reichelderfer M, Dove WF. Intestinal adenomas can develop with a stable karyo-type and stable microsatellites. Proc Natl Acad Sci U S A 2002;99:8927-31.
16. Min/+ mice. Proc Natl Acad Sci U S A 1998;95:10826-31.
17. Bacher JW, Abdel Megid WM, Kent-First MG, Halberg RB. Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumors. Mol Carcinog 2005;44:285-92.
18. Snijders AM, Nowak NJ, Huey B, et al. Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Res 2005;15: 302-11.
19. Cormier RT, Hong KH, Halberg RB, et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 1997;17:88-91.
20. Petrini JH, Theunissen JW. Double strand break metabolism and cancer susceptibility: lessons from the mre11 complex. Cell Cycle 2004;3:541-2.
21. Chen X, Halberg RB, Burch RP, Dove WF. Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition. J Mol Histol 2008; 39:283-94.
22. Shoemaker AR, Moser AR, Dove WF. N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res 1995;55:4479-85.
23. Beck JA, Lloyd S, Hafezparast M, et al. Genealogies of mouse inbred strains. Nat Genet 2000;24:23-5.
24. Lifsted T, Le Voyer T, Williams M, et al. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 1998;77:640-4.
25. Park YG, Zhao X, Lesueur F, et al. Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet 2005;37:1055-62.
26. Baran AA, Silverman KA, Zeskand J, et al. The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. Genome Res 2007;17: 566-76.
27. Min/+ on mouse chromosome 18. Genetics 2007;176:1237-44.
28. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954;8:1-12.
29. Smits R, Kartheuser A, Jagmohan-Changur S, et al. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis 1997;18:321-7.
30. Shoemaker AR, Luongo C, Moser AR, Marton LJ, Dove WF. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. Cancer Res 1997;57:1999-2006.
31. Janssen KP, Alberici P, Fsihi H, et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 2006;131:1096-109.
32. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
33. Alberici P, De Pater E, Cardoso J, et al. Aneuploidy arises at early stages of Apc-driven intestinal tumorigenesis and pinpoints conserved chromosomal loci of allelic imbalance between mouse and human. Am J Pathol 2007;170:377-87.
34. Martin ES, Tonon G, Sinha R, et al. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res 2007;67:10736-43.
35. Sieber OM, Lamlum H, Crabtree MD, et al. Wholegene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas. Proc Natl Acad Sci U S A 2002; 99:2954-8.
36. Luo G, Santoro IM, McDaniel LD, et al. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 2000;26:424-9.
37. Goss KH, Risinger MA, Kordich JJ, et al. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 2002;297:2051-3.
38. Haigis KM, Dove WF. A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity. Nat Genet 2003;33:33-9.
39. McMurray MA, Gottschling DE. An age-induced switch to a hyper-recombinational state. Science 2003; 301:1908-11.
40. Issa JP. Colon cancer: it's CIN or CIMP. Clin Cancer Res 2008;14:5939-40.
41. Yatabe Y, Tavare S, Shibata D. Investigating stem cells in human colon by using methylation patterns. Proc Natl Acad Sci U S A 2001;98:10839-44.
42. Kim JY, Siegmund KD, Tavare S, Shibata D. Age-related human small intestine methylation: evidence for stem cell niches. BMC Med 2005;3:10.
43. Tomlinson IP, Novelli MR, Bodmer WF. The mutation rate and cancer. Proc Natl Acad Sci U S A 1996;93: 14800-3.
44. Bodmer W. Genetic instability is not a requirement for tumor development. Cancer Res 2008;68:3558-60.
45. Rusan NM, Peifer M. Original CIN: reviewing roles for APC in chromosome instability. J Cell Biol 2008; 181:719-26.
46. Weaver BA, Cleveland DW. Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res 2007;67: 10103-5.
47. Min/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc Natl Acad Sci U S A 2005;102:4365-70.
48. Yao X, Buermeyer AB, Narayanan L, et al. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc Natl Acad Sci U S A 1999;96:6850-5.